Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting, 64480 [2020-22464]

Download as PDF 64480 Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2020–0100] Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); October 28–29, 2020, 10:00 a.m.–5:30 p.m., EDT (times subject to change), in the original Federal Register notice. The meeting, which was published in the Federal Register on September 21, 2020, Volume 85, Number 183, pages 59317–59318, is being amended and should read as follows: SUMMARY: The virtual meeting will be held on October 28–30, 2020, from 10:00 a.m.–5:30 p.m., EDT (times subject to change). The meeting is open to the public. Written comments must be received on or before October 30, 2020. ADDRESSES: For more information on ACIP please visit the ACIP website: https://www.cdc.gov/vaccines/acip/ index.html. You may submit comments, identified by Docket No. CDC–2020–0100 by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Docket No. CDC–2020–0100, c/o Attn: October ACIP Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24–8, Atlanta, GA 30329–4027. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, khammond on DSKJM1Z7X2PROD with NOTICES DATES: National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MS–H24–8, Atlanta, GA 30329– 4027; Telephone: 404–639–8367; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–22464 Filed 10–9–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Formative Data Collections for ACF Program Support (OMB #0970–0531) Office of Planning, Research, and Evaluation, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: The Administration for Children and Families (ACF) proposes to revise the existing overarching generic clearance for Formative Data Collections for ACF Program Support (OMB #0970–0531) to increase the estimated number of respondents and, therefore, the overall burden estimate. DATES: Comments due within 60 days of publication. In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described above. ADDRESSES: Copies of the proposed collection of information can be obtained and comments may be forwarded by emailing OPREinfocollection@acf.hhs.gov. SUMMARY: Alternatively, copies can also be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C Street SW, Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All requests emailed or written should be identified by the title of the information collection. SUPPLEMENTARY INFORMATION: Description: The goals of the generic information collections under this approval are to obtain information about program and grantee processes or needs, and to inform the following types of activities, among others: • Delivery of targeted assistance and workflows related to program and grantee processes, and the development and refinement of recordkeeping and communication systems. • Planning for provision of programmatic or evaluation-related training or technical assistance (T/TA). • Obtaining grantee or other stakeholder input on the development of program performance measures. • Use of rapid-cycle testing activities to strengthen programs in preparation for summative evaluations. ACF uses a variety of techniques such as semi-structured discussions, focus groups, surveys, templates, open-ended requests, and telephone or in-person interviews, in order to reach these goals. Following standard OMB requirements, OPRE will submit a change request for each individual data collection activity under this generic clearance. Each request will include the individual instrument(s), a justification specific to the individual information collection, and any supplementary documents. OMB should review requests within 10 days of submission. Respondents: Example respondents include: Current or prospective service providers, training or T/TA providers, grantees, contractors, current and potential participants in ACF programs or similar comparison groups, experts in fields pertaining to ACF programs, key stakeholder groups involved in ACF projects and programs, individuals engaged in program re-design or demonstration development for evaluation, state or local government officials, or others involved in or prospectively involved in ACF programs. ANNUAL BURDEN ESTIMATES Estimated total number of respondents Instrument Semi-Structured Discussions and Focus Groups ................................... VerDate Sep<11>2014 18:52 Oct 09, 2020 Jkt 253001 PO 00000 Frm 00040 Fmt 4703 Number of responses per respondent 5,000 Sfmt 4703 E:\FR\FM\13OCN1.SGM Average burden hours per response 1 13OCN1 Annual burden hours 2 10,000

Agencies

[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Page 64480]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22464]



[[Page 64480]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0100]


Advisory Committee on Immunization Practices (ACIP); Amended 
Notice of Meeting

SUMMARY: Notice is hereby given of a change in the meeting of the 
Advisory Committee on Immunization Practices (ACIP); October 28-29, 
2020, 10:00 a.m.-5:30 p.m., EDT (times subject to change), in the 
original Federal Register notice. The meeting, which was published in 
the Federal Register on September 21, 2020, Volume 85, Number 183, 
pages 59317-59318, is being amended and should read as follows:

DATES: The virtual meeting will be held on October 28-30, 2020, from 
10:00 a.m.-5:30 p.m., EDT (times subject to change). The meeting is 
open to the public.
    Written comments must be received on or before October 30, 2020.

ADDRESSES: For more information on ACIP please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/.
    You may submit comments, identified by Docket No. CDC-2020-0100 by 
any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket No. CDC-2020-0100, c/o Attn: October ACIP 
Meeting, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H24-8, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: The Director, Strategic Business Initiatives 
Unit, Office of the Chief Operating Officer, Centers for Disease 
Control and Prevention, has been delegated the authority to sign 
Federal Register notices pertaining to announcements of meetings and 
other committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-22464 Filed 10-9-20; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.